HISAMITSU PHARMACEUTICAL CO.,INC. [4530.T]
TOKYO, Apr 13 (Pulse News Wire) – Hisamitsu Pharmaceutical Co.,inc. (4530.T) announced today that its board of directors has decided on the nominees for the upcoming annual shareholders meeting scheduled for May 28, 2026. All ten incumbent directors will complete their terms upon the conclusion of the meeting, and the company plans to recommend the following candidates: - Nakatomi Kazuhide (Current Representative Director) - Saito Kyuu (Current Director) - Tsutumi Nobuo (Current Director) - Murayama Shinichi (Current Director) - Takiyama Koji (Current Director) - Isobe Yuuichi (Current Director) - Yanosaka Sakae (New Appointment; Current Senior Executive Officer) - Matsuo Tettsugo (External Director; Current External Director) - Watanabe Tamako (External Director; Current External Director) - Noguchi Midori (External Director; Current External Director) Additionally, Anzai Yuichiro, currently serving as an external director, will retire from his position.
🟢 Confidence: High AI-translated content.